Breaking
•[Clinical Rounds] Generalised eruptive histiocytosis mimicking lymphoma relapse in a patient with previous diffuse large B-cell lymphoma•[Countdown] The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all•[Articles] Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China•[Articles] Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials•[Articles] Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial•[Department of Error] Department of Error•[Correspondence] Women with obstetric fistula in Somalia deserve better•[Correspondence] Global health: dying from failure or fulfilment?•[Correspondence] North Korea's health revolution in its 2026 medical journals•[Perspectives] Tobacco exposure: online exhibitions at CSTS•[Perspectives] High-risk pregnancy after Dobbs: who is allowed to choose?•[Perspectives] Jemilah Mahmood: Malaysian leadership in planetary health•[World Report] India to cap the cost of 137 cancer drugs•[World Report] Global Fund appoints Mark Dybul as head•[Comment] Offline: China bids to lead in global health•[Comment] Global health reform is missing a generation•[Comment] Beyond the models: addressing the catastrophic health threats facing humanity requires a holistic approach•[Comment] Multiple standards of care in non-small-cell lung cancer after EGFR-TKI therapy: progress, fragmentation, or inevitability?•[Comment] Faster troponin, same time in the emergency department: what is next for acute coronary syndrome assessment?•[Editorial] Climate change and health: 10 years on, what next?•[Clinical Rounds] Generalised eruptive histiocytosis mimicking lymphoma relapse in a patient with previous diffuse large B-cell lymphoma•[Countdown] The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all•[Articles] Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China•[Articles] Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials•[Articles] Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial•[Department of Error] Department of Error•[Correspondence] Women with obstetric fistula in Somalia deserve better•[Correspondence] Global health: dying from failure or fulfilment?•[Correspondence] North Korea's health revolution in its 2026 medical journals•[Perspectives] Tobacco exposure: online exhibitions at CSTS•[Perspectives] High-risk pregnancy after Dobbs: who is allowed to choose?•[Perspectives] Jemilah Mahmood: Malaysian leadership in planetary health•[World Report] India to cap the cost of 137 cancer drugs•[World Report] Global Fund appoints Mark Dybul as head•[Comment] Offline: China bids to lead in global health•[Comment] Global health reform is missing a generation•[Comment] Beyond the models: addressing the catastrophic health threats facing humanity requires a holistic approach•[Comment] Multiple standards of care in non-small-cell lung cancer after EGFR-TKI therapy: progress, fragmentation, or inevitability?•[Comment] Faster troponin, same time in the emergency department: what is next for acute coronary syndrome assessment?•[Editorial] Climate change and health: 10 years on, what next?
TheNewsPulse.pro
Home/business/community/government
business

Keep or sell Konsa? - FPL gameweek 10 dilemmas

Confidence92·multiple reportsImportance96NP-EVT-20261105-611F289

BBC Sport's Fantasy Premier League expert FPL Heisenberg gives his answers to some of the biggest dilemmas facing managers in gameweek 10.

Read the original at the primary source
Keep or sell Konsa? - FPL gameweek 10 dilemmas
11/5/2026, 10:26:23 PM

Additional coverage (1)

Also on the network: airlinesairports · farmerspulse · foodpulse · indias · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —